The Pulse

Overview

The Pulse is a single vial blend of two growth hormone secretagogues, CJC-1295 and Ipamorelin, that work through two complementary pathways to prompt the body’s own release of growth hormone. CJC-1295 is a synthetic analog of growth hormone releasing hormone, modified for a longer and more sustained signal. The pairing is one of the most studied combinations in growth hormone axis research.

What it combines and why

CJC-1295 acts on the growth hormone releasing hormone receptor in the pituitary to amplify the natural release signal in a sustained way, while Ipamorelin acts on the separate ghrelin receptor to trigger a cleaner, sharper pulse of growth hormone. Research pairs them because one provides a steady background signal and the other a sharp pulse, in effect opening two different doors to the same gland at once. The idea studied is whether the two pathways together produce a fuller pulsatile release than either alone, while still working with the body’s natural rhythm.

What researchers study

Studies examine the two pathways for stimulating the body’s own pulsatile growth hormone release, with CJC-1295 studied as a long acting growth hormone releasing hormone analog and Ipamorelin for its selective pulse, as described in the Ipamorelin entry. The framing throughout is on the body’s own signaling rather than on outcomes. CJC-1295 does not have a standalone library page, so its references are listed here.

See the Ipamorelin entry. CJC-1295 references: Raun K et al. and Bowers CY, Growth Hormone & IGF Research, 2012.

Research Use Only. Not for human or animal use.

BUNDLED KITS (individual vials)